The effects of canagliflozin compared to sitagliptin on cardiorespiratory fitness in type 2 diabetes mellitus and heart failure with reduced ejection fraction: The CANA‐HF study

BACKGROUND: Canagliflozin reduces hospitalizations for heart failure (HF) in type 2 diabetes mellitus (T2DM). Its effect on cardiorespiratory fitness and cardiac function in patients with established HF with reduced ejection fraction (HFrEF) is unknown. METHODS: We conducted a double‐blind randomize...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Diabetes Metab Res Rev
Glavni autori: Carbone, Salvatore, Billingsley, Hayley E., Canada, Justin M., Bressi, Edoardo, Rotelli, Brando, Kadariya, Dinesh, Dixon, Dave L., Markley, Roshanak, Trankle, Cory R., Cooke, Richard, Rao, Krishnasree, B. Shah, Keyur, Medina de Chazal, Horacio, Chiabrando, Juan Guido, Vecchié, Alessandra, Dell, Megan, L. Mihalick, Virginia, Bogaev, Roberta, Hart, Linda, Van Tassell, Benjamin W., Arena, Ross, Celi, Francesco S., Abbate, Antonio
Format: Artigo
Jezik:Inglês
Izdano: John Wiley & Sons, Inc. 2020
Teme:
Research Articles
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7685099/
https://ncbi.nlm.nih.gov/pubmed/32415802
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/dmrr.3335
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items